|
Ryan A. Harris is a Principal working on U.S. venture and growth capital in the healthcare sector. He is based in New York.
Prior to joining Carlyle in 2002, Dr. Harris was a consultant in the West Coast Healthcare Practice of McKinsey & Co., working with a variety of biotechnology, pharmaceutical and medical device companies on corporate, R&D and marketing strategy.
Dr. Harris holds an M.D. from the University of California, San Francisco, School of Medicine. He received an M.S. in health research and policy and B.A. in psychology from Stanford University, and attended Oxford University's Magdalen College. He has authored over 25 scientific articles in peer-reviewed publications such as JAMA, Lancet, Annals of Internal Medicine, and the Journal of Health Economics.
Dr. Harris serves as a present or former member or observer on the Board of Directors for Align Technologies, AqueSys, ConnectiCare, MedPointe Pharmaceuticals, Qualicaps, Inc., Transport Pharmaceuticals, Proteus Biomedical and NeoVista. | 